Blog: REVELATION BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) –

Item 7.01 Regulation FD Disclosure

On January 11, 2022, Revelation Biosciences, Inc. (“Revelation”) posted an
investor presentation on its website,

The information in this Item 7.01 (including Exhibit 99.1) is being furnished
and shall not be deemed to be filed for purposes of Section 18 of the Exchange
Act, or otherwise be subject to the liabilities of that section, nor shall it be
deemed to be incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act.

Item 9.01. Financial Statements and Exhibits

(c) Exhibits:

Exhibit No.   Description
99.1            Investor Presentation January 2022
104           Cover Page Interactive Data File (embedded within the Inline XBRL document)


© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s